RNT Health Insights Receives Second US FDA Breakthrough Device Designation for Esophageal ...
PNN Chandigarh [India] January 9 RNT Health Insights a Chandigarh-based health-tech startup specializing in AI-assisted ...
Approved drug dronedarone found to inhibit the proliferation of esophageal squamous cell ...
Esophageal squamous cell carcinoma (ESCC) is a severe health threat, being a predominant subtype of esophageal cancer and ...
Targeted Oncology5 天
ESOPEC & TRANSMET Trials Show Promise Across GI Cancers
Mark A. Lewis, MD, discussed the promise of the ESOPEC and TRANSMET trials and the need for their further investigation.
Too Old to Operate5 天
Timely Endoscopic Follow-Up for Synchronous SESCC After HNSCC Treatment
The following is a summary of “Impact of preceding treatment for head and neck squamous cell carcinoma on synchronous ...
expresshealthcare5 天
Chandigarh startup RNT Health Insights secures US FDA breakthrough designation for ...
Innovative AI-assisted diagnostic tool aims to improve early detection of esophageal cancer and enhance survival outcomes ...
Chip Chick on MSN6 天
Some Cancer Genes Could Play A Role In Protecting You
New research suggests a genetic mutation previously believed to promote esophageal cancer might actually play a protective ...
来自MSN6 天
Unexpected Role for CDKN2A Gene in Esophageal Cancer Progression
Scientists from the Barts Cancer Institute and the Francis Crick Institute have demonstrated that a genetic flaw that has ...
Astellas Pharma : China's NMPA Approves VYLOY For Advanced Gastric/Gastroesophageal ...
Astellas Pharma Inc. (ALPMY, ALPMY) announced that China's National Medical Products Administration approved VYLOY (zolbetuximab), in ...
Pharmaceutical Technology6 天
LY-4101174 by Eli Lilly and Co for Esophageal Cancer: Likelihood of Approval
LY-4101174 is under clinical development by Eli Lilly and Co and currently in Phase I for Esophageal Cancer. According to GlobalData, Phase I drugs for Esophageal Cancer have an 80% phase transition ...